In vitro antimicrobial and modulatory activity of the natural products silymarin and silibinin

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Rakelly De Oliveira, Dayanne ^a   Relison Tintino, Saulo ^b   Morais Braga, Maria Flaviana Bezerra ^b   Boligon, Aline Augusti ^a   Linde Athayde, Margareth ^a   Douglas Melo Coutinho, Henrique ^b   De Menezes, Irwin Rose Alencar ^b   Fachinetto, Roselei ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b REGIONAL UNIVERSITY OF CARIRI   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEBENDAZOLE; NYSTATIN; SILIBININ; SILYMARIN;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG POTENTIATION; ESCHERICHIA COLI; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; SILYBUM MARIANUM;

EID: 84925607498     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/292797     Document Type: Article

References (46)

1. S. Gibbons, "Anti-staphylococcal plant natural products," Natural Product Reports, vol. 21, no. 2, pp. 263-277, 2004.
2. M. Otto, "Basis of virulence in community-associated methi-cillin-resistant Staphylococcus aureus," Annual Review of Microbiology, vol. 64, pp. 143-162, 2010.
3. P. Seymour and J. Golding, "Hospital-acquired and community-acquired MRSA: two distinct infections," Emergency Medicine, vol. 41, no. 10, pp. 36-41, 2009.
4. S. Watt, P. Lanotte, L. Mereghetti, M. Moulin-Schouleur, B. Picard, and R. Quentin, "Escherichia coli strains from pregnant women and neonates: intraspecies genetic distribution and prevalence of virulence factors," Journal of Clinical Microbiology, vol. 41, no. 5, pp. 1929-1935, 2003.
5. R. L. Vogt and L. Dippold, "Escherichia coli O157:H7 outbreak associated with consumption of ground beef, June-July 2002," Public Health Reports, vol. 120, no. 2, pp. 174-178, 2005.
6. C. van Delden and B. H. Iglewski, "Cell-to-cell signaling and Pseudomonas aeruginosa infections," Emerging Infectious Diseases, vol. 4, no. 4, pp. 551-560, 1998.
7. E. J. Muñoz-Elías and J. D. McKinney, "Bacterial persistence: strategies for survival," in Immunology of Infectious Diseases, S. H. E. Kaufmann, A. Sher, and R. Ahmed, Eds., pp. 331-355, ASM Press, Washington, DC, USA, 2002.
8. R. C. Moellering, "Novos desafos no campo das doenças infecciosas," in Patógenos Emergentes nas Doeņcas Infecciosas: Relatório Especial Hospital Práctice, Euromédice, Edições Médicas, Oeiras, Portugal, 2000.
9. I. F. Silva Jr., V. C. Filho, S. A. Zacchino, J. C. D. S. Lima, and D. T. D. O. Martins, "Antimicrobial screening of some medicinal plants from Mato Grosso Cerrado," Brazilian Journal of Phar-macognosy, vol. 19, no. 1, pp. 242-248, 2009.
10. Z. A. Kanafani and J. R. Perfect, "Resistance to antifungal agents: mechanisms and clinical impact," Clinical Infectious Diseases, vol. 46, no. 1, pp. 120-128, 2008.
11. R. S. Almeida, Micologia, Ciências Farmacêuticas, Rio de Janeiro, Brazil, 2008.
12. P. Morazzoni and E. Bombardelli, "Silybum marianum (Carduus marianus)," Fitoterapia, vol. 66, no. 1, pp. 3-42, 1995.
13. C. Loguercio and D. Festi, "Silybin and the liver: from basic research to clinical practice," World Journal of Gastroenterology, vol. 17, no. 18, pp. 2288-2301, 2011.
14. H. Wagner, L. Hörhammer, and R. Münster, "On the chemistry of silymarin (silybin), the active principle of the fruits from Silybum marianum (L.) Gaertn. (Carduus marianus L.)," Arzneimittel-Forschung/Drug Research, vol. 18, no. 6, pp. 688-696, 1968.
15. C. Nencini, G. Giorgi, and L. Micheli, "Protective efect of sily-marin on oxidative stress in rat brain," Phytomedicine, vol. 14, no. 2-3, pp. 129-135, 2007.
16. A. Valenzuela and R. Guerra, "Protective efect of the favonoid silybin dihemisuccinate on the toxicity of phenylhydrazine on rat liver," FEBS Letters, vol. 181, no. 2, pp. 291-294, 1985.
17. R. Saller, R. Meier, and R. Brignoli, "Te use of silymarin in the treatment of liver diseases," Drugs, vol. 61, no. 14, pp. 2035-2063, 2001.
18. A. Miadonna, A. Tedeschi, E. Leggieri, M. Lorini, M. Froldi, and C. Zanussi, "Efects of silybin on histamine release from human basophil leucocytes," British Journal of Clinical Pharmacology, vol. 24, no. 6, pp. 747-752, 1987.
19. S. K. Katiyar, N. J. Korman, H. Mukhtar, and R. Agarwal, "Protective efects of silymarin against photocarcinogenesis in a mouse skin model," Journal of the National Cancer Institute, vol. 89, no. 8, pp. 556-566, 1997.
20. G. Boigk, L. Stroedter, H. Herbst, J. Waldschmidt, E. O. Riecken, and D. Schuppan, "Silymarin retards collagen accumulation in early and advanced biliary fbrosis secondary to complete bile duct obliteration in rats," Hepatology, vol. 26, no. 3, pp. 643-649, 1997.
21. Y.-S. Lee, K.-A. Jang, and J.-D. Cha, "Synergistic antibacterial efect between silibinin and antibiotics in oral bacteria," Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 618081, 7 pages, 2012.
22. A. A. Boligon, T. G. Schwanz, M. Piana et al., "Chemical composition and antioxidant activity of the essential oil of Tabernaemontana catharinensis A. DC. leaves," Natural Product Research, vol. 27, no. 1, pp. 68-71, 2013.
23. NCCLS-National Comitte for CLinical Laboratory Standards, Methods for Dilution Antimicrobial Susceptibility Testes for Bacteria Tat Grow Aerobically, vol. 20, NCCLS Approved Standard M7-A5, Villanova, Pa, USA, 6th edition, 2005.
24. J.-C. Palomino, A. Martin, M. Camacho, H. Guerra, J. Swings, and F. Portaels, "Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis," Antimicrobial Agents and Chemotherapy, vol. 46, no. 8, pp. 2720-2722, 2002.
25. M. M. Javadpour, M. M. Juban, W.-C. J. Lo et al., "De novo antimicrobial peptides with low mammalian cell toxicity," Journal of Medicinal Chemistry, vol. 39, no. 16, pp. 3107-3113, 1996.
26. H. D. M. Coutinho, J. G. M. Costa, V. S. Falcão-Silva, J. P. Siqueira Jr., and E. O. Lima, "Efect of Momordica charantia L. in the resistance to aminoglycosides in methicilin-resistant Staphylococcus aureus," Comparative Immunology, Microbiology and Infectious Disease, vol. 33, no. 6, pp. 467-471, 2010.
27. V. Kuete, J. Kamga, L. P. Sandjo et al., "Antimicrobial activities of the methanol extract, fractions and compounds from Ficus polita Vahl. (Moraceae)," BMC Complementary and Alternative Medicine, vol. 11, article 6, 2011.
28. Y. Bibi, S. Nisa, F. M. Chaudhary, and M. Zia, "Antibacterial activity of some selected medicinal plants of Pakistan," BMC Complementary and Alternative Medicine, vol. 11, article 52, 2011.
29. F. Hadacek and H. Greger, "Testing of antifungal natural products: methodologies, comparability of results and assay choice," Phytochemical Analysis, vol. 11, no. 3, pp. 137-147, 2000.
30. V. Šimánek, V. Kren, J. Ulrichová, J. Vicar, and L. Cvak, "Sily-marin: what is in the name.? An appeal for a change of editorial policy," Hepatology, vol. 32, no. 2, pp. 442-444, 2000.
31. V. KŘen and D. Walterová, "Silybin and silymarin-new efects and applications," Biomedical Papers, vol. 149, no. 1, pp. 29-41, 2005.
32. B. P. Jacobs, C. Dennehy, G. Ramirez, J. Sapp, and V. A. Lawrence, "Milk thistle for the treatment of liver disease: a systematic review and meta-analysis," The American Journal of Medicine, vol. 113, no. 6, pp. 506-515, 2002.
33. G. L. Dong, K. K. Hyung, Y. Park et al., "Gram-positive bacteria specifc properties of silybin derived from Silybum marianum," Archives of Pharmacal Research, vol. 26, no. 8, pp. 597-600, 2003.
34. D. C. Michelin, P. E. Moreschi, A. C. Lima, G. G. F. Nascimento, M. O. Paganelli, and M. V. Chaud, "Avaliação da atividade antimicrobiana de extratos vegetais," Revista Brasileira de Far-macognosia, vol. 15, no. 4, 2005.
35. J. A. S. Zuanazzi and J. A. Montanha, "Flavonóides," in Far-macognosia: da planta ao medicamento, C. M. O. Simões, E. P. Schenkel, G. Gosmann, J. C. Mello, L. A. Mentz, and P. R. Petro-vick, Eds., pp. 577-614, Editora da UFRGS, Porto Alegre, Brazil, 5th edition, 2004.
36. M. Daglia, "Polyphenols as antimicrobial agents," Current Opinion in Biotechnology, vol. 23, no. 2, pp. 174-181, 2012.
37. H. Tsuchiya, M. Sato, T. Miyazaki et al., "Comparative study on the antibacterial activity of phytochemical favanones against methicillin-resistant Staphylococcus aureus," Journal of Ethnopharmacology, vol. 50, no. 1, pp. 27-34, 1996.
38. S. Burt, "Essential oils: their antibacterial properties and potential applications in foods-a review," International Journal of Food Microbiology, vol. 94, no. 3, pp. 223-253, 2004.
39. C. N. Wendakoon and M. Sakaguchi, "Inhibition of amino acid decarboxylase activity of Enterobacter aerogenes by active components in spices," Journal of Food Protection, vol. 58, no. 3, pp. 280-283, 1995.
40. H. N. H. Veras, F. F. G. Rodrigues, A. V. Colares et al., "Syner-gistic antibiotic activity of volatile compounds from the essential oil of Lippia sidoides and thymol," Fitoterapia, vol. 83, no. 3, pp. 508-512, 2012.
41. H. D. M. Coutinho, A. Vasconcellos, M. A. Lima, G. G. Almeida-Filho, and R. R. N. Alves, "Termite usage associated with antibiotic therapy: enhancement of aminoglycoside antibiotic activity by natural products of Nasutitermes corniger (Mot-schulsky 1855)," BMC Complementary and Alternative Medicine, vol. 9, no. 1, article 35, 7 pages, 2009.
42. Q. Wang, H. Wang, and M. Xie, "Antibacterial mechanism of soybean isofavone on Staphylococcus aureus," Archives of Microbiology, vol. 192, no. 11, pp. 893-898, 2010.
43. H. P. Ávila, E. D. F. A. Smânia, F. D. Monache, and A. Smânia, "Structure-activity relationship of antibacterial chalcones," Bioorganic and Medicinal Chemistry, vol. 16, no. 22, pp. 9790-9794, 2008.
44. Y. Li, Y. Luo, Y. Hu et al., "Design, synthesis and antimicrobial activities of nitroimidazole derivatives containing 1, 3, 4-oxadiazole scafold as FabH inhibitors," Bioorganic and Medicinal Chemistry, vol. 20, no. 14, pp. 4316-4322, 2012.
45. P. M. Salas, G. Céliz, H. Geronazzo, M. Daz, and S. L. Resnik, "Antifungal activity of natural and enzymatically-modifed fav-onoids isolated from citrus species," Food Chemistry, vol. 124, no. 4, pp. 1411-1415, 2011.
46. T. Arif, T. K. Mandal, and R. Dabur, "Natural products: anti-fungal agents derived from plants," in Opportunity, Challenge and Scope of Natural Products in Medicinal Chemistry, vol. 81, pp. 283-311, 2011.